Permanent and temporary implantation of I-125 brachytherapy sources has become an official method for the treatment of different cancers. In this technique, it is essential to determine dose distribution around the brachytherapy source to choose the optimal treatment plan. In this study, the dosimetric parameters for a new interstitial brachytherapy source I-125 (IrSeed-125) were calculated with GATE/GEANT4 Monte Carlo code. Dose rate constant, radial dose function and 2D anisotropy function were calculated inside a water phantom (based on the recommendations of TG-43U1 protocol), and inside several tissue phantoms around the IrSeed-125 capsule. Acquired results were compared with MCNP simulation and experimental data. The dose rate constant of IrSeed-125 in the water phantom was about 1.038 cGy·h−1U−1 that shows good consistency with the experimental data. The radial dose function at 0.5, 0.9, 1.8, 3 and 7 cm radial distances were obtained as 1.095, 1.019, 0.826, 0.605, and 0.188, respectively. The results of the IrSeed-125 is not only in good agreement with those calculated by other simulation with MCNP code but also are closer to the experimental results. Discrepancies in the estimation of dose around IrSeed-125 capsule in the muscle and fat tissue phantoms are greater than the breast and lung phantoms in comparison with the water phantom. Results show that GATE/GEANT4 Monte Carlo code produces accurate results for dosimetric parameters of the IrSeed-125 LDR brachytherapy source with choosing the appropriate physics list. There are some differences in the dose calculation in the tissue phantoms in comparison with water phantom, especially in long distances from the source center, which may cause errors in the estimation of dose around brachytherapy sources that are not taken account by the TG43-U1 formalism.
Photon beams with wide energy ranges from 4 MV to 25 MV are commonly used in radiotherapy nowadays. In recent years, there has been a strong interest in a certain modification of a radiotherapeutic apparatus by the application of the so-called flattening filter-free (FFF) beam. Several advantages of FFF beams over standard flattening filter (FF) beams are noticed, and this technical solution has aroused great interest among radiotherapeutic facilities. The goal of the present study is to investigate the differences between the conventional FF and unflattened FFF 6-MV and 10-MV photon beams in some basic dosimetric parameters and their influence on the whole radiotherapeutic treatment. The data provided here include the detailed characteristics as follows: percent depth dose (PDD), beam profile, edge of a half-profile, total scatter correction factor (TSCF) and head scatter correction factor (HSCF) for FF and FFF 6-MV and 10-MV photon beams from the Elekta Versa HD accelerator in the Katowice Oncology Center in Poland.
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.